QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Phreesia, Inc. (PHR)

Healthcare

No action
Fundamental
3
Sentiment
2
Technical
3

Do Nothing: qualitativeScore 2 is below the required floor of 3 - the upstream qualitative screen flagged a disqualifying condition (no actionable catalyst, flat sentiment delta, indeterminate retail) and no chart pattern overrides it; the SHADOW sum-gate branch is unavailable because the shadow flag rendered false. Chart-wise a ~12.05 pullback limit is structurally valid (Change-A stop 11.59, R/R 2.00) while a 12.86 breakout buy-stop fails the R/R floor (0.91), but neither is admissible under the qualitative hard block.

Analysis as of 2026-11-03· more than 2 trading days ago

Company overview

Phreesia, Inc. provides a cloud-based SaaS and payment platform for the healthcare sector in the U.S. and Canada, streamlining patient intake and payment processes. Its platform includes mobile applications, web portals, and on-site kiosks, offering solutions for patient registration, revenue cycle management, and clinical support.

Fundamental

fair
Fundamental3
Mixed but improving

Phreesia's fundamentals show cash generation and refinancing progress, but growth deceleration and legal overhangs present challenges.

Phreesia is a healthcare SaaS and payments platform at an inflection point: it turned cash-flow positive (FY2026 operating cash flow $78.8M; H1 FY2027 $42.3M) and modestly GAAP-profitable, refinanced its acquisition bridge debt into a five-year revolver, and holds a net-cash TTM position — yet revenue growth has cooled to low double digits with the subscription line slightly declining, the Altman Z-Score sits in the distress zone on an accumulated-deficit artifact, interest coverage is thin, and two securities class actions plus a restructuring and a shelf registration temper the picture. Valuation is split: cheap on free-cash-flow yield (~12.3%) and EV/Sales (~1.23x) with a $12 analyst consensus target above the $10.17 quote, but expensive on earnings and the DCF-implied upside looks like aggressive model extrapolation. Overall a mixed but improving fundamental profile.

Sentiment

weak
Sentiment2
Flat sentiment

Sentiment remains flat with no retail interest or actionable catalysts in the near term.

No actionable catalyst exists in the 1-30 day window: the only first-party PRs of the last 30 days are two Becker's employee-recognition awards (announced, non-material), the 2026-09-02 Q2 FY2027 print is 62 days trailing, and the in-window Citizens note was a Market Perform reiteration excluded by taxonomy. Sentiment is a determinate flat delta (+0.08 baseline to +0.03 scoring, both windows measured) with retail effectively absent, and the Red-Flag Screen is clean - the securities class-action alerts remain unconfirmed law-firm marketing (regulator_confirmed_count = 0, case search CAPTCHA-blocked) rather than a docket-confirmed action, so no cap applies.

Technical

fair
Technical3
Consolidation phase

The stock is in a consolidation phase with a positive trend but cooling momentum.

Chart read (score 3): PHR is in a constructive daily uptrend - close 12.23 sits above SMA20 11.70, SMA50 11.06, SMA200 10.88, EMA21 11.80 and WMA21 12.06, with ADX14 32.96 confirming a strong directional trend. But short-term momentum is cooling: price has slipped below EMA9 12.27, WMA9 12.42, DEMA14 12.61 and TEMA14 12.68, MACD histogram has collapsed from 0.26 (2026-10-23) to 0.04 while remaining positive (line 0.48 > signal 0.44 > 0), and RSI14 has eased from 76.1 to 61.8 - a consolidation, not a breakdown. Williams %R -27.80 and StdDev20 0.82 reinforce a mid-range, two-sided tape. Mixed-positive chart = 3. The trade is not actionable: qualitativeScore 2 < 3 is a hard block, and the SHADOW sum-gate branch is unavailable because the shadow flag rendered false.

You’re looking at 2026-11-03 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.